分享到:

扩大溶栓时间窗的神经影像策略研究进展

现阶段随机临床试验结果表明,惟一能改善急性缺血性卒中患者结局的是超早期(3 h内)采取标准化组织型纤溶酶原激活剂(  (本文共6页) 阅读全文>>

《中华医学杂志》2006年10期
中华医学杂志

血管内再通治疗对急性缺血性卒中的患者有效

2006年2月的《卒中》杂志(Stroke,2006,37:419424)报告,对于不适宜做静脉内溶栓的卒中患者,血管内再通治疗(e...  (本文共1页) 阅读全文>>

《世界核心医学期刊文摘(神经病学分册)》2006年03期
世界核心医学期刊文摘(神经病学分册)

高密度征逆转预示急性缺血性卒中患者的恢复

Background and Purpose -The presence of computed tomography dense signs in acute ischemic stroke indicates thrombosis. We sought to ascertain whether reversibility of these signs provides additional prognostic information. Methods -Baseline and follow-up imaging was obtained from 18 patients who had received intra venous abciximab and heparin as part of an ongoing safety study in acute ischemic stroke. Presence of si...  (本文共2页) 阅读全文>>

《世界核心医学期刊文摘(神经病学分册)》2006年Z1期
世界核心医学期刊文摘(神经病学分册)

NXY-059治疗急性缺血性卒中

Background: NXY-059 is a free-radical-trapping agent that is neuroprotective in animal models of stroke. We tested whether it would reduce disability in humans after acute ischemic stroke. Methods: We conducted a randomized, double-blind, placebo-controlled trial involving 1722 patients with acute ischemic stroke who were randomly assigned to receive a 72-hour infusion of placebo or intravenous NXY-059 within 6 hours...  (本文共1页) 阅读全文>>

《世界核心医学期刊文摘(神经病学分册)》2006年12期
世界核心医学期刊文摘(神经病学分册)

全波兰卒中预防和治疗注册参与中心的急性缺血性卒中护理和预后

BACKGROUND AND PURPOSE-Significant intercenter variability in quality of care and stroke outcomes was found in many countries.The aim of the study was to compare the acute ischemic stroke care and outcomes in centers participating in the Polish National Stroke Prevention and Treatment Registry.METHODS-The World Health Organization Step-wise Approach to Stroke Surveillance-based questionnaire was used to collect data ...  (本文共1页) 阅读全文>>

《国际脑血管病杂志》2006年04期
国际脑血管病杂志

支架辅助颅内血管再通治疗急性缺血性卒中

对于不适合行静脉组织型纤溶酶原激活物(tissue plasminogen activator,tPA)的急性缺血性卒中...  (本文共1页) 阅读全文>>